Hemorrhagic activity of HF3, a snake venom metalloproteinase: insights from the proteomic analysis of mouse skin and blood plasma.
暂无分享,去创建一个
J. Fox | N. Sherman | A. F. Paes Leme | S. Serrano | D. Smalley | Ana K Oliveira | L. O. Sizukusa | Milene C Menezes | A. P. Paes Leme
[1] J. Fox,et al. New insights into the structural elements involved in the skin haemorrhage induced by snake venom metalloproteinases , 2010, Thrombosis and Haemostasis.
[2] N. Yamanouye,et al. Mechanisms of Vascular Damage by Hemorrhagic Snake Venom Metalloproteinases: Tissue Distribution and In Situ Hydrolysis , 2010, PLoS neglected tropical diseases.
[3] J. Fox,et al. Wound exudate as a proteomic window to reveal different mechanisms of tissue damage by snake venom toxins. , 2009, Journal of proteome research.
[4] J. Fox,et al. Simplified procedures for the isolation of HF3, bothropasin, disintegrin-like/cysteine-rich protein and a novel P-I metalloproteinase from Bothrops jararaca venom. , 2009, Toxicon : official journal of the International Society on Toxinology.
[5] G. Sperk,et al. Afamin is synthesized by cerebrovascular endothelial cells and mediates α‐tocopherol transport across an in vitro model of the blood–brain barrier , 2009, Journal of neurochemistry.
[6] J. Fox,et al. Activation of leukocyte rolling by the cysteine‐rich domain and the hyper‐variable region of HF3, a snake venom hemorrhagic metalloproteinase , 2008, FEBS letters.
[7] J. Fox,et al. Insights into and speculations about snake venom metalloproteinase (SVMP) synthesis, folding and disulfide bond formation and their contribution to venom complexity , 2008, The FEBS journal.
[8] J. Fox,et al. Use of SILAC for exploring sheddase and matrix degradation of fibroblasts in culture by the PIII SVMP atrolysin A: identification of two novel substrates with functional relevance. , 2007, Archives of biochemistry and biophysics.
[9] D. Hafler,et al. Protective and therapeutic role for αB-crystallin in autoimmune demyelination , 2007, Nature.
[10] J. Fox,et al. Interaction of the cysteine‐rich domain of snake venom metalloproteinases with the A1 domain of von Willebrand factor promotes site‐specific proteolysis of von Willebrand factor and inhibition of von Willebrand factor‐mediated platelet aggregation , 2007, The FEBS journal.
[11] Johanna Ivaska,et al. Novel functions of vimentin in cell adhesion, migration, and signaling. , 2007, Experimental cell research.
[12] A. Allison,et al. Interaction of an annexin V homodimer (Diannexin) with phosphatidylserine on cell surfaces and consequent antithrombotic activity , 2007, Thrombosis and Haemostasis.
[13] M. Baker,et al. Evaluation of endogenous plasma peptide extraction methods for mass spectrometric biomarker discovery. , 2007, Journal of proteome research.
[14] D. Hafler,et al. Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination. , 2007, Nature.
[15] L. Formigli,et al. Cytoskeletal reorganization in skeletal muscle differentiation: from cell morphology to gene expression. , 2007, European journal of histochemistry : EJH.
[16] Deyu Wang,et al. The Cysteine-rich Domain of Snake Venom Metalloproteinases Is a Ligand for von Willebrand Factor A Domains , 2006, Journal of Biological Chemistry.
[17] J. Fox,et al. Novel insights into capillary vessel basement membrane damage by snake venom hemorrhagic metalloproteinases: a biochemical and immunohistochemical study. , 2006, Archives of biochemistry and biophysics.
[18] Deyu Wang,et al. Function of the cysteine-rich domain of the haemorrhagic metalloproteinase atrolysin A: targeting adhesion proteins collagen I and von Willebrand factor. , 2005, The Biochemical journal.
[19] C. Moskaluk,et al. Role of the snake venom toxin jararhagin in proinflammatory pathogenesis: in vitro and in vivo gene expression analysis of the effects of the toxin. , 2005, Archives of biochemistry and biophysics.
[20] Stephen Barnes,et al. Prospective highlights of functional skin proteomics. , 2005, Mass spectrometry reviews.
[21] K. Clemetson,et al. Snake venoms and hemostasis , 2005, Journal of thrombosis and haemostasis : JTH.
[22] G. Amarante-Mendes,et al. Jararhagin, a snake venom metalloproteinase, induces a specialized form of apoptosis (anoikis) selective to endothelial cells , 2005, Apoptosis.
[23] Y. Asada,et al. Hemoglobin stimulates the expression of matrix metalloproteinases, MMP‐2 and MMP‐9 by synovial cells: A possible cause of joint damage after intra‐articular hemorrhage , 2005, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[24] Julian White. Snake venoms and coagulopathy. , 2005, Toxicon : official journal of the International Society on Toxinology.
[25] J. Gutiérrez,et al. Hemorrhage induced by snake venom metalloproteinases: biochemical and biophysical mechanisms involved in microvessel damage. , 2005, Toxicon : official journal of the International Society on Toxinology.
[26] J. Fox,et al. A multifaceted analysis of viperid snake venoms by two‐dimensional gel electrophoresis: An approach to understanding venom proteomics , 2005, Proteomics.
[27] C. Teixeira,et al. Activation of alpha(M)beta(2)-mediated phagocytosis by HF3, a P-III class metalloproteinase isolated from the venom of Bothrops jararaca. , 2004, Biochemical and biophysical research communications.
[28] J. Garin,et al. AHNAK interaction with the annexin 2/S100A10 complex regulates cell membrane cytoarchitecture , 2004, The Journal of cell biology.
[29] J. Gutiérrez,et al. Skeletal muscle degeneration induced by venom phospholipases A2: insights into the mechanisms of local and systemic myotoxicity. , 2003, Toxicon : official journal of the International Society on Toxinology.
[30] J. White. ADAMs: modulators of cell-cell and cell-matrix interactions. , 2003, Current opinion in cell biology.
[31] J. Fox,et al. Identification of sites in the cysteine‐rich domain of the class P‐III snake venom metalloproteinases responsible for inhibition of platelet function , 2003, FEBS letters.
[32] D. Markovitz,et al. Vimentin is secreted by activated macrophages , 2003, Nature Cell Biology.
[33] N. Anderson,et al. The Human Plasma Proteome , 2002, Molecular & Cellular Proteomics.
[34] J. Fox,et al. The Reprolysin Jararhagin, a Snake Venom Metalloproteinase, Functions as a Fibrillar Collagen Agonist Involved in Fibroblast Cell Adhesion and Signaling* , 2002, The Journal of Biological Chemistry.
[35] G. Tsurupa,et al. Interaction of fibrin(ogen) with fibronectin: further characterization and localization of the fibronectin-binding site. , 2002, Biochemistry.
[36] F. Altruda,et al. Hemopexin: structure, function, and regulation. , 2002, DNA and cell biology.
[37] A. Görg,et al. Improved silver staining protocols for high sensitivity protein identification using matrix‐assisted laser desorption/ionization‐time of flight analysis , 2001, Proteomics.
[38] J. Goldberg,et al. Comparison of proteins expressed by Pseudomonas aeruginosa strains representing initial and chronic isolates from a cystic fibrosis patient: an analysis by 2-D gel electrophoresis and capillary column liquid chromatography-tandem mass spectrometry. , 2000, Microbiology.
[39] J. Fox,et al. Inhibition of platelet aggregation by the recombinant cysteine-rich domain of the hemorrhagic snake venom metalloproteinase, atrolysin A. , 2000, Archives of biochemistry and biophysics.
[40] B. Tang,et al. ADAMTS: A novel family of proteases with an ADAM protease domain and thrombospondin 1 repeats , 1999, FEBS letters.
[41] J. Fox,et al. The Interglobular Domain of Cartilage Aggrecan Is Cleaved by Hemorrhagic Metalloproteinase HT-d (Atrolysin C) at the Matrix Metalloproteinase and Aggrecanase Sites* , 1998, The Journal of Biological Chemistry.
[42] C. Hay,et al. Inhibition of collagen-induced platelet aggregation as the result of cleavage of alpha 2 beta 1-integrin by the snake venom metalloproteinase jararhagin. , 1996, The Biochemical journal.
[43] J. Gutiérrez,et al. Local tissue damage induced by BaP1, a metalloproteinase isolated from Bothrops asper (Terciopelo) snake venom. , 1995, Experimental and molecular pathology.
[44] J. Fox,et al. Snake venom metalloendopeptidases: reprolysins. , 1995, Methods in enzymology.
[45] J. Slupsky,et al. Properties of Fibrinogen Cleaved by Jararhagin, a Metalloproteinase from the Venom of Bothrops jararaca , 1994, Thrombosis and Haemostasis.
[46] J. Fox,et al. Hemorrhagic metalloproteinases from snake venoms. , 1994, Pharmacology & therapeutics.
[47] M. Yanagishita. Function of proteoglycans in the extracellular matrix , 1993, Acta pathologica japonica.
[48] J. Catanese,et al. Isolation from opossum serum of a metalloproteinase inhibitor homologous to human alpha 1B-glycoprotein. , 1992, Biochemistry.
[49] D. Purich,et al. Microtubule protein ADP-ribosylation in vitro leads to assembly inhibition and rapid depolymerization. , 1992, Biochemistry.
[50] J. Fox,et al. Interaction of hemorrhagic metalloproteinases with human alpha 2-macroglobulin. , 1990, Biochemistry.
[51] J. Fox,et al. Degradation of extracellular matrix proteins by hemorrhagic metalloproteinases. , 1989, Archives of biochemistry and biophysics.
[52] J. Fox,et al. Amino acid sequence of a Crotalus atrox venom metalloproteinase which cleaves type IV collagen and gelatin. , 1989, The Journal of biological chemistry.
[53] S. Carson,et al. Tissue factor (coagulation factor III) inhibition by apolipoprotein A-II. , 1987, The Journal of biological chemistry.
[54] A. P. Reichl,et al. Comparison of immunological, biochemical and biophysical properties of three hemorrhagic factors isolated from the venom of Bothrops jararaca (jararaca). , 1986, Toxicon : official journal of the International Society on Toxinology.
[55] A. Tu,et al. Hemorrhagic toxins from rattlesnake (Crotalus atrox) venom. Pathogenesis of hemorrhage induced by three purified toxins. , 1978, The American journal of pathology.
[56] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[57] H. Ikezawa,et al. Haemorrhagic activities of habu snake venom, and their relations to lethal toxicity, proteolytic activities and other pathological activities. , 1960, British journal of experimental pathology.